Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18F-FDG PET study

Autor: Rabiner, Eugenii A., Tzimopoulou, Sofia, Cunningham, Vincent J., Jeter, Barbara, Zvartau-Hind, Marina, Castiglia, Mary, Mistry, Praful, Bird, Nick P., Matthews, Julian, Whitcher, Brandon, Nichols, Thomas E., Lai, Robert, Lotay, Narinder, Saunders, Ann, Reiman, Eric, Chen, Kewei, Gold, Mike, Matthews, Paul M.
Zdroj: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2009 5(4) Supplement:P39-P40
Databáze: ScienceDirect